Actively Recruiting
Chemotherapy Induced Peripheral Neurotoxicity (CIPN): Why Should we Care
Led by University of Milano Bicocca · Updated on 2025-07-29
150
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a pilot, observational, cross-sectional, study on socio-economic burden related to chemotherapy-induced peripheral neurotoxicity (CIPN). Investigators will collect CIPN healthcare related costs on a detailed clinical patient-level. As a sub-study, data obtained in this cross-sectional study, will be compared with administrative larger datasets on patients affected by cancer. The aim is to run a test for potential proxy variables which are available in larger administrative datasets, even if not directly measuring CIPN, to learn more about the impact of CIPN.
CONDITIONS
Official Title
Chemotherapy Induced Peripheral Neurotoxicity (CIPN): Why Should we Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cancer patients either before first chemotherapy cycle without neuropathy or after chemotherapy with stable CIPN
- At least 75 patients before first chemotherapy with TNSc score of 0 (no neuropathy)
- At least 75 patients with stable CIPN after chemotherapy completion for at least 2 months with TNSc score 1 or higher
- Male and female subjects aged 18 years or older
- Subjects who provide informed consent
- Willingness to complete all study activities and follow-up visits
- Karnofsky performance score of 70 or higher
You will not qualify if you...
- Presence of other neurological conditions such as brain tumor or brain/spinal metastases
- Severe depression complicating assessments
- Current use of medications other than chemotherapy that cause peripheral nerve toxicity
- Medical conditions causing neuropathy like diabetes
- Any condition that might reduce the chance of obtaining satisfactory study data as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ASST Monza
Monza, Italy, 20900
Actively Recruiting
Research Team
P
Paola Alberti, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here